$AVXL..agree. The data is encouraging data just wanted to see it on a larger scale of patients. That will be even more impactful then where as now still lots of unknowns. Same thing we always have until we have Phase 3 data. That is more important than ever in Alzheimer's disease where we have had so many drug failure candidates.
Message in reply to:
AVXL...The trial has not progressed far enough for the data on the other patients perhaps? Your thoughts?
News 
Market Data 
Discover 
AI
